These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 7976393)

  • 1. Biochemical effect and kinetics of thrombin inhibition by GYKI-14766.
    Bakonyi A; Kovács L; Duong HT; Arányi P
    Acta Physiol Hung; 1994; 82(1):29-36. PubMed ID: 7976393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibition of blood coagulation by tripeptide aldehydes--a retrospective screening study focused on the stable D-MePhe-Pro-Arg-H.H2SO4.
    Bagdy D; Barabás E; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):325-30. PubMed ID: 1641823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals. New orally active stable analogs of D-Phe-Pro-Arg-H.
    Bajusz S; Barabás E; Fauszt I; Fehér A; Horváth G; Juhász A; Szabó AG; Széll E
    Bioorg Med Chem; 1995 Aug; 3(8):1079-89. PubMed ID: 7582981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2-disubstituted cyclohexane derived tripeptide aldehydes as novel selective thrombin inhibitors.
    Harmat NJ; Di Bugno C; Criscuoli M; Giorgi R; Lippi A; Martinelli A; Monti S; Subissi A
    Bioorg Med Chem Lett; 1998 May; 8(10):1249-54. PubMed ID: 9871744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by D-MePhe-Pro-Arg-H (GYKI-14766) of thrombus growth in experimental models of thrombosis.
    Bagdy D; Szabó G; Barabás E; Bajusz S
    Thromb Haemost; 1992 Aug; 68(2):125-9. PubMed ID: 1412156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active and selective anticoagulants: D-Phe-Pro-Arg-H, a free tripeptide aldehyde prone to spontaneous inactivation, and its stable N-methyl derivative, D-MePhe-Pro-Arg-H.
    Bajusz S; Szell E; Bagdy D; Barabas E; Horvath G; Dioszegi M; Fittler Z; Szabo G; Juhasz A; Tomori E
    J Med Chem; 1990 Jun; 33(6):1729-35. PubMed ID: 2342067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.
    Jackson CV; Crowe VG; Frank JD; Wilson HC; Coffman WJ; Utterback BG; Jakubowski JA; Smith GF
    J Pharmacol Exp Ther; 1992 May; 261(2):546-52. PubMed ID: 1578372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active site-directed thrombin inhibitors: alpha-hydroxyacyl-prolyl-arginals, new orally active stable analogues of D-Phe-Pro-Arg-H.
    Bajusz S; Barabas E; Fauszt I; Feher A; Horvath G; Juhasz A; Szabo GA; Szell E
    Semin Thromb Hemost; 1996; 22(3):243-6. PubMed ID: 8836008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic system.
    Jesty J
    Blood; 1985 Nov; 66(5):1189-95. PubMed ID: 4052633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family of arginal thrombin inhibitors related to efegatran.
    Smith GF; Shuman RT; Craft TJ; Gifford DS; Kurz KD; Jones ND; Chirgadze N; Hermann RB; Coffman WJ; Sandusky GE; Roberts E; Jackson CV
    Semin Thromb Hemost; 1996; 22(2):173-83. PubMed ID: 8807715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo anticoagulant and antiplatelet effect of D-Phe-Pro-Arg-H and D-MePhe-Pro-Arg-H.
    Bagdy D; Barabás E; Szabó G; Bajusz S; Széll E
    Thromb Haemost; 1992 Mar; 67(3):357-65. PubMed ID: 1641827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological aspects in the studies on the mechanism of action of synthetic direct thrombin antagonists.
    Bagdy D; Barabás E; Szabó G
    Acta Physiol Hung; 1994; 82(4):355-63. PubMed ID: 7785446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood.
    Wagner WR; Hubbell JA
    J Lab Clin Med; 1990 Nov; 116(5):636-50. PubMed ID: 2104522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equilibrium binding of thrombin to platelets.
    Martin BM; Wasiewski WW; Fenton JW; Detwiler TC
    Biochemistry; 1976 Nov; 15(22):4886-93. PubMed ID: 990249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of glycoprotein Ib and the seven transmembrane domain receptor to increases in platelet cytoplasmic [Ca2+] induced by alpha-thrombin.
    Greco NJ; Tandon NN; Jones GD; Kornhauser R; Jackson B; Yamamoto N; Tanoue K; Jamieson GA
    Biochemistry; 1996 Jan; 35(3):906-14. PubMed ID: 8547272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA; Walsh PN
    Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological effects of the direct thrombin inhibitor AR-H067637.
    Deinum J; Mattsson C; Inghardt T; Elg M
    Thromb Haemost; 2009 Jun; 101(6):1051-9. PubMed ID: 19492147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective albumin-binding surfaces modified with a thrombin-inhibiting peptide.
    Freitas SC; Maia S; Figueiredo AC; Gomes P; Pereira PJ; Barbosa MA; Martins MC
    Acta Biomater; 2014 Mar; 10(3):1227-37. PubMed ID: 24316365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.